Cross-source evidence timeline
Orforglipron research timeline
Follow 33 selected, directly cited source records from July 1, 2025 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight.↗
PubMed lists PMID 41994902 in Diabetes, obesity & metabolism as Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: April 17, 2026 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
Orforglipron for Obstructive Sleep Apnea: Research Summary.↗
PubMed lists PMID 43002163 in JAMA as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 9, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07794579↗
PeptideScanner retained ClinicalTrials.gov record NCT07794579 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06672549↗
PeptideScanner retained ClinicalTrials.gov record NCT06672549 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06672939↗
PeptideScanner retained ClinicalTrials.gov record NCT06672939 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07202884↗
PeptideScanner retained ClinicalTrials.gov record NCT07202884 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07223593↗
PeptideScanner retained ClinicalTrials.gov record NCT07223593 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07241390↗
PeptideScanner retained ClinicalTrials.gov record NCT07241390 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06192108↗
PeptideScanner retained ClinicalTrials.gov record NCT06192108 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07790861↗
PeptideScanner retained ClinicalTrials.gov record NCT07790861 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07153471↗
PeptideScanner retained ClinicalTrials.gov record NCT07153471 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07613307↗
PeptideScanner retained ClinicalTrials.gov record NCT07613307 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06109311↗
PeptideScanner retained ClinicalTrials.gov record NCT06109311 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-01, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06649045↗
PeptideScanner retained ClinicalTrials.gov record NCT06649045 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-14, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05872620↗
PeptideScanner retained ClinicalTrials.gov record NCT05872620 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05971940↗
PeptideScanner retained ClinicalTrials.gov record NCT05971940 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07739537↗
PeptideScanner retained ClinicalTrials.gov record NCT07739537 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05869903↗
PeptideScanner retained ClinicalTrials.gov record NCT05869903 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Literature metadata
Orforglipron (Foundayo) for adults with obesity.↗
PubMed lists PMID 42420063 in Trends in pharmacological sciences as Journal Article, with publication-date metadata of 2026-07-08 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 8, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06993792↗
PeptideScanner retained ClinicalTrials.gov record NCT06993792 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06972459↗
PeptideScanner retained ClinicalTrials.gov record NCT06972459 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT07729332↗
PeptideScanner retained ClinicalTrials.gov record NCT07729332 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Literature metadata
Orforglipron Calcium.↗
PubMed lists PMID 42138709 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2026-07-22 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 22, 2026 · day precisionAdded to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT05931380↗
PeptideScanner retained ClinicalTrials.gov record NCT05931380 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06370728↗
PeptideScanner retained ClinicalTrials.gov record NCT06370728 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06440980↗
PeptideScanner retained ClinicalTrials.gov record NCT06440980 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06010004↗
PeptideScanner retained ClinicalTrials.gov record NCT06010004 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06704763↗
PeptideScanner retained ClinicalTrials.gov record NCT06704763 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-26, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Clinical trials
ClinicalTrials.gov record NCT06186622↗
PeptideScanner retained ClinicalTrials.gov record NCT06186622 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was orforglipron.↗
Added to PeptideScanner November 16, 2026Regulatory
Drugs@FDA application NDA220934↗
The official Drugs@FDA dataset lists original submission 1 for NDA 220934 with status AP dated 2026-04-01, and names orforglipron calcium among the application record's active ingredients.↗
Added to PeptideScanner November 17, 2026
Source year
2025
Literature metadata
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.↗
PubMed lists PMID 38091541 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 14, 2023 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.↗
PubMed lists PMID 38091542 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 14, 2023 · day precisionAdded to PeptideScanner November 16, 2026Literature metadata
GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply.↗
PubMed lists PMID 38091543 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 14, 2023 · day precisionAdded to PeptideScanner November 16, 2026